The Peritoneal Cavity Is a Distinct Compartment of Angiogenic Molecular Mediators

Robert Nachtsheim, Ben Dudley, Paul L McNeil, Thomas R. Howdieshell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: This study was designed to analyze porcine plasma and peritoneal fluid for concentration differences of angiogenic molecular mediators and to determine local peritoneal sites of production of these molecules. Background: The peritoneum is now recognized as a dynamic cellular membrane with important functions, including antigen presentation; transport and movement of fluid, solutes, and particulate matter across serosal cavities; and secretion of glycosaminoglycans, extracellular matrix proteins, proinflammatory cytokines, and growth factors. The mechanisms of the peritoneal response to injury and the factors that determine the outcome of the reactive or reparative processes of the peritoneum remain poorly defined. Methods: Domestic swine (n = 12) underwent percutaneous diagnostic peritoneal lavage to obtain preincision peritoneal fluid for biochemical analysis. Open biopsy samples of parietal peritoneum and omentum were obtained for immunochemical and molecular analysis. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) levels were quantitated by enzyme-linked immunosorbent assay, and nitrite/nitrate (NOx) measured by nonenzymatic assay. Sections of formalin-fixed tissue were stained for immunoreactivity to VEGF, bFGF, and nitric oxide synthase (NOS). Frozen homogenized peritoneum and omentum were prepared for isolation of protein and RNA. An endothelial growth assay was created using human umbilical vein endothelial cells cultured with peritoneal fluid with or without anti-VEGF or anti-bFGF antibodies. Results: The mean plasma concentrations of VEGF, bFGF, and NOx were 20 ± 5 pg/mL, 35 ± 9 pg/mL, and 4.5 ± 1.3 μm, compared with mean peritoneal fluid concentrations of 395 ± 75 pg/mL, 486 ± 72 pg/mL, and 35.0 ± 8.8 μm respectively (P < 0.05 for each molecule). Immunochemistry demonstrated VEGF, bFGF, and NOS protein in mesothelium, submesothelium, and omentum. The use of Western blotting and reverse transcription polymerase chain reaction confirmed peritoneal and omental presence of VEGF and NOS-2. The use of endothelial bioassay documented peritoneal fluid angiogenic activity, which was inhibited by addition of neutralizing antibody to VEGF or bFGF. Conclusion: Peritoneal compartmentalization of angiogenic mediators important in wound healing, inflammation, and tumor growth suggests that the plasma concentrations of these mediators do not reflect their tissue concentrations or local biological activity.

Original languageEnglish (US)
Pages (from-to)28-35
Number of pages8
JournalJournal of Surgical Research
Volume134
Issue number1
DOIs
StatePublished - Jul 1 2006

Fingerprint

Peritoneal Cavity
Vascular Endothelial Growth Factor A
Fibroblast Growth Factor 2
Ascitic Fluid
Peritoneum
Omentum
Nitric Oxide Synthase
Swine
Peritoneal Lavage
Immunochemistry
Particulate Matter
Extracellular Matrix Proteins
Human Umbilical Vein Endothelial Cells
Antigen Presentation
Growth
Nitrites
Neutralizing Antibodies
Glycosaminoglycans
Biological Assay
Nitrates

Keywords

  • basic fibroblast growth factor
  • mesothelium
  • nitric oxide
  • nitric oxide synthase
  • peritoneum
  • vascular endothelial growth factor

ASJC Scopus subject areas

  • Surgery

Cite this

The Peritoneal Cavity Is a Distinct Compartment of Angiogenic Molecular Mediators. / Nachtsheim, Robert; Dudley, Ben; McNeil, Paul L; Howdieshell, Thomas R.

In: Journal of Surgical Research, Vol. 134, No. 1, 01.07.2006, p. 28-35.

Research output: Contribution to journalArticle

Nachtsheim, Robert ; Dudley, Ben ; McNeil, Paul L ; Howdieshell, Thomas R. / The Peritoneal Cavity Is a Distinct Compartment of Angiogenic Molecular Mediators. In: Journal of Surgical Research. 2006 ; Vol. 134, No. 1. pp. 28-35.
@article{9819eea7d3534bf6ab7e77223ca425e9,
title = "The Peritoneal Cavity Is a Distinct Compartment of Angiogenic Molecular Mediators",
abstract = "Objective: This study was designed to analyze porcine plasma and peritoneal fluid for concentration differences of angiogenic molecular mediators and to determine local peritoneal sites of production of these molecules. Background: The peritoneum is now recognized as a dynamic cellular membrane with important functions, including antigen presentation; transport and movement of fluid, solutes, and particulate matter across serosal cavities; and secretion of glycosaminoglycans, extracellular matrix proteins, proinflammatory cytokines, and growth factors. The mechanisms of the peritoneal response to injury and the factors that determine the outcome of the reactive or reparative processes of the peritoneum remain poorly defined. Methods: Domestic swine (n = 12) underwent percutaneous diagnostic peritoneal lavage to obtain preincision peritoneal fluid for biochemical analysis. Open biopsy samples of parietal peritoneum and omentum were obtained for immunochemical and molecular analysis. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) levels were quantitated by enzyme-linked immunosorbent assay, and nitrite/nitrate (NOx) measured by nonenzymatic assay. Sections of formalin-fixed tissue were stained for immunoreactivity to VEGF, bFGF, and nitric oxide synthase (NOS). Frozen homogenized peritoneum and omentum were prepared for isolation of protein and RNA. An endothelial growth assay was created using human umbilical vein endothelial cells cultured with peritoneal fluid with or without anti-VEGF or anti-bFGF antibodies. Results: The mean plasma concentrations of VEGF, bFGF, and NOx were 20 ± 5 pg/mL, 35 ± 9 pg/mL, and 4.5 ± 1.3 μm, compared with mean peritoneal fluid concentrations of 395 ± 75 pg/mL, 486 ± 72 pg/mL, and 35.0 ± 8.8 μm respectively (P < 0.05 for each molecule). Immunochemistry demonstrated VEGF, bFGF, and NOS protein in mesothelium, submesothelium, and omentum. The use of Western blotting and reverse transcription polymerase chain reaction confirmed peritoneal and omental presence of VEGF and NOS-2. The use of endothelial bioassay documented peritoneal fluid angiogenic activity, which was inhibited by addition of neutralizing antibody to VEGF or bFGF. Conclusion: Peritoneal compartmentalization of angiogenic mediators important in wound healing, inflammation, and tumor growth suggests that the plasma concentrations of these mediators do not reflect their tissue concentrations or local biological activity.",
keywords = "basic fibroblast growth factor, mesothelium, nitric oxide, nitric oxide synthase, peritoneum, vascular endothelial growth factor",
author = "Robert Nachtsheim and Ben Dudley and McNeil, {Paul L} and Howdieshell, {Thomas R.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.jss.2006.03.008",
language = "English (US)",
volume = "134",
pages = "28--35",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The Peritoneal Cavity Is a Distinct Compartment of Angiogenic Molecular Mediators

AU - Nachtsheim, Robert

AU - Dudley, Ben

AU - McNeil, Paul L

AU - Howdieshell, Thomas R.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Objective: This study was designed to analyze porcine plasma and peritoneal fluid for concentration differences of angiogenic molecular mediators and to determine local peritoneal sites of production of these molecules. Background: The peritoneum is now recognized as a dynamic cellular membrane with important functions, including antigen presentation; transport and movement of fluid, solutes, and particulate matter across serosal cavities; and secretion of glycosaminoglycans, extracellular matrix proteins, proinflammatory cytokines, and growth factors. The mechanisms of the peritoneal response to injury and the factors that determine the outcome of the reactive or reparative processes of the peritoneum remain poorly defined. Methods: Domestic swine (n = 12) underwent percutaneous diagnostic peritoneal lavage to obtain preincision peritoneal fluid for biochemical analysis. Open biopsy samples of parietal peritoneum and omentum were obtained for immunochemical and molecular analysis. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) levels were quantitated by enzyme-linked immunosorbent assay, and nitrite/nitrate (NOx) measured by nonenzymatic assay. Sections of formalin-fixed tissue were stained for immunoreactivity to VEGF, bFGF, and nitric oxide synthase (NOS). Frozen homogenized peritoneum and omentum were prepared for isolation of protein and RNA. An endothelial growth assay was created using human umbilical vein endothelial cells cultured with peritoneal fluid with or without anti-VEGF or anti-bFGF antibodies. Results: The mean plasma concentrations of VEGF, bFGF, and NOx were 20 ± 5 pg/mL, 35 ± 9 pg/mL, and 4.5 ± 1.3 μm, compared with mean peritoneal fluid concentrations of 395 ± 75 pg/mL, 486 ± 72 pg/mL, and 35.0 ± 8.8 μm respectively (P < 0.05 for each molecule). Immunochemistry demonstrated VEGF, bFGF, and NOS protein in mesothelium, submesothelium, and omentum. The use of Western blotting and reverse transcription polymerase chain reaction confirmed peritoneal and omental presence of VEGF and NOS-2. The use of endothelial bioassay documented peritoneal fluid angiogenic activity, which was inhibited by addition of neutralizing antibody to VEGF or bFGF. Conclusion: Peritoneal compartmentalization of angiogenic mediators important in wound healing, inflammation, and tumor growth suggests that the plasma concentrations of these mediators do not reflect their tissue concentrations or local biological activity.

AB - Objective: This study was designed to analyze porcine plasma and peritoneal fluid for concentration differences of angiogenic molecular mediators and to determine local peritoneal sites of production of these molecules. Background: The peritoneum is now recognized as a dynamic cellular membrane with important functions, including antigen presentation; transport and movement of fluid, solutes, and particulate matter across serosal cavities; and secretion of glycosaminoglycans, extracellular matrix proteins, proinflammatory cytokines, and growth factors. The mechanisms of the peritoneal response to injury and the factors that determine the outcome of the reactive or reparative processes of the peritoneum remain poorly defined. Methods: Domestic swine (n = 12) underwent percutaneous diagnostic peritoneal lavage to obtain preincision peritoneal fluid for biochemical analysis. Open biopsy samples of parietal peritoneum and omentum were obtained for immunochemical and molecular analysis. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) levels were quantitated by enzyme-linked immunosorbent assay, and nitrite/nitrate (NOx) measured by nonenzymatic assay. Sections of formalin-fixed tissue were stained for immunoreactivity to VEGF, bFGF, and nitric oxide synthase (NOS). Frozen homogenized peritoneum and omentum were prepared for isolation of protein and RNA. An endothelial growth assay was created using human umbilical vein endothelial cells cultured with peritoneal fluid with or without anti-VEGF or anti-bFGF antibodies. Results: The mean plasma concentrations of VEGF, bFGF, and NOx were 20 ± 5 pg/mL, 35 ± 9 pg/mL, and 4.5 ± 1.3 μm, compared with mean peritoneal fluid concentrations of 395 ± 75 pg/mL, 486 ± 72 pg/mL, and 35.0 ± 8.8 μm respectively (P < 0.05 for each molecule). Immunochemistry demonstrated VEGF, bFGF, and NOS protein in mesothelium, submesothelium, and omentum. The use of Western blotting and reverse transcription polymerase chain reaction confirmed peritoneal and omental presence of VEGF and NOS-2. The use of endothelial bioassay documented peritoneal fluid angiogenic activity, which was inhibited by addition of neutralizing antibody to VEGF or bFGF. Conclusion: Peritoneal compartmentalization of angiogenic mediators important in wound healing, inflammation, and tumor growth suggests that the plasma concentrations of these mediators do not reflect their tissue concentrations or local biological activity.

KW - basic fibroblast growth factor

KW - mesothelium

KW - nitric oxide

KW - nitric oxide synthase

KW - peritoneum

KW - vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=33745000690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745000690&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2006.03.008

DO - 10.1016/j.jss.2006.03.008

M3 - Article

VL - 134

SP - 28

EP - 35

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -